Pulmonary surfactants affinity Pluronic-hybridized liposomes enhance the treatment of drug-resistant lung cancer

• Published in: International journal of pharmaceutics Vol. 607; p. 120973
• Main Authors: Wang, Rui, Sun, Yali, He, Wenxiu, Chen, Yiting, Lu, Enhao, Sha, Xianyi
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 25.09.2021
• Subjects: Ambroxol; Autophagy; Liposome; Multi-drug resistance (MDR); Non-small cell lung cancer (NSCLC); Pluronic P105; Liposome; Ambroxol; Pluronic P105; Autophagy; Multi-drug resistance (MDR); Non-small cell lung cancer (NSCLC)
• ISSN: 0378-5173; 1873-3476
• DOI: 10.1016/j.ijpharm.2021.120973

[Display omitted] For a long time, the incidence and mortality of lung cancer have ranked first among all kinds of cancers, of which the major type is non-small cell lung cancer (NSCLC). Until now, chemotherapy and radiotherapy are still the first choice for patients with advanced or metastatic NSCLC. However, the emergence of multi-drug resistance (MDR) always leads to the failure of chemotherapy and increases cancer-related mortality. In this study, we prepared a Pluronic-hybridized paclitaxel-loaded liposome (PPL), which was used in combination with ambroxol (Ax) to not only resensitize drug-resistant tumor cells, but also increase the preparation retention in the lung. On the one hand, Ax induced the production of pulmonary surfactants (PS) and responsively improved the accumulation of pulmonary surfactants affinity liposomes whose skeleton was exogenous pulmonary surfactant phospholipids DPPC, because of the specific affinity of phospholipids related to pulmonary surfactant proteins. On the other hand, drug-resistant tumor cells were resensitized due to the inhibition of autophagy by Ax and the reduced expression of the drug-resistant protein P-glycoprotein (P-gp) by Pluronic P105. Therefore, we concluded that the combination of PPL and Ax achieved excellent killing tumor effects through multi-path and multi-strategy, having great application prospects in the future.